Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07222722

NIRS Monitoring in the NICU and AKI

Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
24 Weeks – 30 Weeks
Healthy volunteers
Accepted

Summary

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Conditions

Interventions

TypeNameDescription
DEVICENIRS MonitoringThe renal NIRS device is a non-invasive tool that uses near-infrared light to measure oxygen saturation various tissues. Renal NIRS sensors will be placed by 24 hours of the participants' admission.

Timeline

Start date
2025-11-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2025-10-30
Last updated
2025-10-30

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07222722. Inclusion in this directory is not an endorsement.

NIRS Monitoring in the NICU and AKI (NCT07222722) · Clinical Trials Directory